Pulmonary Fibrosis/Interstitial Lung Disease Program
The Pulmonary Fibrosis/Interstitial Lung Disease Program treats patients with pulmonary fibrosis (IPF), interstitial lung disease (ILD), collagen vascular-associated pulmonary diseases, Hermansky-Pudlack Syndrome, histiocytosis X, tuberous sclerosis, LAM, glycogen storage disease (Gauchers), secondary pulmonary hypertension, and stage IV sarcoidosis. All of these patients require intensive medical attention, close follow-up, and other extensive services, which will lead to:
Improved outcome/survival for patients with IPF and ILD
Improved quality of life and increased patient satisfaction by meeting their medical, as well as psychosocial needs
Collaboration with the Palliative Care Service
Also planned are a Visiting Doctor Program and other services, including pathology, radiology, cardiothoracic surgery, cardiology, and, most importantly, lung transplantation. A patient support group is being formed for families and friends, as well as for patients.
The Mount Sinai Hospital ranks among the region's best for respiratory services in the U.S. News & World Report 2013-2014 "Best Hospitals" issue. Read more
The Pulmonary, Critical Care and Sleep Medicine FPA is open from 8 A.M. to 4:30 P.M. Monday through Friday.